Fanaroff Alexander C, Schulteis Ryan D, Pieper Karen S, Rao Sunil V, Newby L Kristin
Division of Cardiology, Duke University Medical Center, Durham, NC (A.C.F., K.N.).
Department of Medicine, Durham VA Medical Center, Durham, NC (R.D.S., S.V.R.).
J Am Heart Assoc. 2015 Dec 14;4(12):e002351. doi: 10.1161/JAHA.115.002351.
It is unclear whether diagnostic protocols based on cardiac markers to identify low-risk chest pain patients suitable for early release from the emergency department can be applied to patients older than 65 years or with traditional cardiac risk factors.
In a single-center retrospective study of 231 consecutive patients with high-risk factor burden in which a first cardiac troponin (cTn) level was measured in the emergency department and a second cTn sample was drawn 4 to 14 hours later, we compared the performance of a modified 2-Hour Accelerated Diagnostic Protocol to Assess Patients with Chest Pain Using Contemporary Troponins as the Only Biomarker (ADAPT) rule to a new risk classification scheme that identifies patients as low risk if they have no known coronary artery disease, a nonischemic electrocardiogram, and 2 cTn levels below the assay's limit of detection. Demographic and outcome data were abstracted through chart review. The median age of our population was 64 years, and 75% had Thrombosis In Myocardial Infarction risk score ≥2. Using our risk classification rule, 53 (23%) patients were low risk with a negative predictive value for 30-day cardiac events of 98%. Applying a modified ADAPT rule to our cohort, 18 (8%) patients were identified as low risk with a negative predictive value of 100%. In a sensitivity analysis, the negative predictive value of our risk algorithm did not change when we relied only on undetectable baseline cTn and eliminated the second cTn assessment.
If confirmed in prospective studies, this less-restrictive risk classification strategy could be used to safely identify chest pain patients with more traditional cardiac risk factors for early emergency department release.
基于心脏标志物的诊断方案用于识别适合从急诊科早期出院的低风险胸痛患者,这一方案是否适用于65岁以上或有传统心脏危险因素的患者尚不清楚。
在一项单中心回顾性研究中,对231例连续的高风险因素负担患者进行研究,这些患者在急诊科测量了首次心肌肌钙蛋白(cTn)水平,并在4至14小时后采集了第二次cTn样本。我们将改良的2小时加速诊断方案(使用当代肌钙蛋白作为唯一生物标志物评估胸痛患者的ADAPT规则)的性能与一种新的风险分类方案进行了比较,该方案将没有已知冠状动脉疾病、非缺血性心电图且2次cTn水平低于检测限的患者识别为低风险。通过病历审查提取人口统计学和结局数据。我们研究人群的中位年龄为64岁,75%的患者心肌梗死血栓形成风险评分≥2。使用我们的风险分类规则,53例(23%)患者为低风险,30天心脏事件的阴性预测值为98%。将改良的ADAPT规则应用于我们的队列,18例(8%)患者被识别为低风险,阴性预测值为100%。在敏感性分析中,当我们仅依赖不可检测的基线cTn并取消第二次cTn评估时,我们的风险算法的阴性预测值没有变化。
如果在前瞻性研究中得到证实,这种限制较少的风险分类策略可用于安全地识别有更多传统心脏危险因素的胸痛患者以便早期从急诊科出院。